Acquisition by Arnold Mitchell of 20000 shares of Petros Pharmaceuticals at 1.41 subject to Rule 16b-3
| PTPIDelisted Stock | USD 0.03 0 13.35% |
Under 61% of Petros Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Petros Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. Petros Pharmaceuticals' investing sentiment shows overall attitude of investors towards Petros Pharmaceuticals.
Petros |
Filed transaction by Petros Pharmaceuticals Officer See Remarks. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Petros Pharmaceuticals Fundamental Analysis
We analyze Petros Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Petros Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Petros Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Petros Pharmaceuticals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Petros Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Petros Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Petros Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Petros Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Petros Pharmaceuticals Related Equities
| BFRI | Biofrontera | 20.00 | ||||
| ISPC | ISpecimen | 6.67 | ||||
| CPHI | China Pharma | 2.75 | ||||
| ENSC | Ensysce Biosciences | 1.36 | ||||
| KTTA | Pasithea Therapeutics | 0 | ||||
| SHPH | Shuttle Pharmaceuticals | 0.52 | ||||
| LGVN | Longeveron LLC | 1.15 | ||||
| AKAN | Akanda Corp | 3.73 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Petros Pink Sheet
If you are still planning to invest in Petros Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Petros Pharmaceuticals' history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |